Novo Nordisk Share Buyback Reaches DKK 7.53B
Novo Nordisk (NYSE:NVO) provides an update on its share repurchase programme conducted under EU Safe…
Novo Nordisk’s Rally Meets a Revenue Reckoning: Buyback Momentum Clashes with 2026 Guidance
Novo Nordisk has staged a striking recovery over the past month, with the stock climbing 17% even as…
Novo Nordisk’s Pipeline and Buyback Offer Twin Props as Wegovy Prescriptions Cool
For Novo Nordisk, the contrast between long-term promise and near-term pressure has rarely been starker. On one side,…
Novo Nordisk’s Buyback Blitz Masks Building Pressure Ahead of 2027 Price Cuts
The Danish pharmaceutical heavyweight is buying back shares at a record pace, yet the same weekly disclosures that…
Novo Nordisk Finds Relief as Rival’s Production Woes and Buyback Bolster Recovery
Novo Nordisk shares have climbed more than 43% from their March nadir, riding a recovery that now draws…
Novo Nordisk Scores Hemophilia Win but Stumbles on Obesity Device as Buyback and India Launch Provid
Novo Nordisk’s stock has clawed back more than 40% from its March nadir, yet the Danish drugmaker’s latest…
Novo Nordisk’s India Insulin Push and Aggressive Buyback Counterbalance a Pipeline Jolt
Novo Nordisk ended the week at €43.32, a 1.29% gain on Friday that masked a slightly negative weekly…
Novo Nordisk Marches Beyond Obesity as Hemophilia Data and Buyback Bolster Confidence
Novo Nordisk’s B-shares closed at €43.32 on Friday, adding 1.29% as the stock continues its recovery from a…
Novo Nordisk Leverages Implant Tech, Oral Pill, and Aggressive Buyback to Counter Eli Lilly’s Moment
The competitive heat from Eli Lilly is forcing Novo Nordisk onto the front foot. The US rival’s tirzepatide…
Novo Nordisk Broadens Arsenal with Implant Deal and MASH Approval as Buyback Sustains Momentum
Novo Nordisk is fighting back against Eli Lilly’s encroachment on multiple fronts — through a novel long-acting implant…
Novo Nordisk Leans on Buyback and Implant Deal as Price Wars Threaten Margins
Novo, Nordisk
Veröffentlicht: 08.07.2026 um 09:09 Uhr,
Redaktion boerse-global.de
Novo Nordisk…
Novo Nordisk: Buyback Support and HSBC Upgrade Fuel Recovery, But Overbought Signals and Analyst Spl
Novo Nordisk’s share price has clawed back ground from March lows, driven by a massive buyback programme and…